联合疗法治疗慢性特发性荨麻疹的疗效观察  

Therapeutic observation of the effect of combining therapy on chronic idiopathic urticaria

作　　者：何金锡[1] 蔡志凌[2] 黄文富[1] 

机构地区：[1]惠州市中心人民医院药剂科,516001 [2]惠州市皮肤病防治研究所,516001

出　　处：《国际医药卫生导报》2009年第6期76-77,83,共3页International Medicine and Health Guidance News

摘　　要：目的观察咪唑斯汀联合雷公藤、雷尼替丁治疗慢性特发性荨麻疹的疗效及安全性。方法随机将92例慢性特发性荨麻疹患者分为三组，治疗组（A组）：服用皿治林、雷公藤多甙及雷尼替丁；对照组1（B组）：服用皿治林及雷公藤多甙；对照组2（C组）：服用咪唑斯汀。连服2周为1疗程，三组均连服2个疗程后观察疗效。结果A、B、C组治愈率分别为52．38％、36％、32％；总有效率分别为90．10％、80％、72％；三组比较，差异有显著性意义（P〈0．01）。结论联合用药治疗慢性特发性荨麻疹安全有效，值得在临床中推广使用。Objective To observe the therapeutic effect and side effect ofmizolastine combined with tripterygium and ranitidine in treating chronic idiopathic urticaria. Methods 92 patients with chronic idiopathic urticaria were divided into three groups randomly. The treatment group（A） were treated with mizolastine combined with tripterygium and ranitidine. The control group 1 （B）were treated with mizolastine combined with tripterygium. The control group 2（C） were treated with mizolastine. The treatment lasted for 4 weeks. Result The effective rates of the three groups were 90.10%,80% and 72%, respectively.The cure rates of the three groups were 52.38%,36% and 32%, respectively. There was statistically significant difference （P〈 0.01 ）. Conclusion Combining Therapy is effective and safc in treating chronic idiopathic urticaria.

关 键 词：咪唑斯汀 雷公藤多甙 雷尼替丁 慢性特发性荨麻疹 

分 类 号：R758[医药卫生—皮肤病学与性病学]